12 results
8-K
EX-99.2
MYGN
Myriad Genetics, Inc.
3 Jun 24
In the Court of Chancery of the State of Delaware
4:06pm
financial statements, misconduct that causes material financial or reputational harm to the Company, or otherwise.
Corporate Governance Enhancements
ARS
2023 FY
MYGN
Myriad Genetics, Inc.
17 Apr 24
Annual report to shareholders
4:33pm
and enforcement by state authorities as well as significant reputational harm. We are currently subject to the HIPAA regulations and maintain an active … in our suffering significant financial or reputational damage. Each of our tests is processed in a single one of our laboratory facilities, and any loss
ARS
2022 FY
MYGN
Myriad Genetics, Inc.
12 Apr 23
Annual report to shareholders
4:10pm
financial or reputational damage. Table of Contents 35
Each of our tests is processed in a single one of our laboratory facilities, and any loss
10-KT
ciwi0uq44zdiln7bl7mt
16 Mar 21
Annual report (with FYE transition)
2:24pm
- Prev
- 1
- Next